| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| B9TWZ6 | Mediator complex subunit MED16 variant MED16_i3; Mediator of RNA polymerase II transcription subunit 16; Fragment; | MED16; | NULL | 537 | human |
| B4DN26 | Tissue-type plasminogen activator chain A; cDNA FLJ59355, highly similar to Tissue-type plasminogen activator (EC 3.4.21.68); | PLAT; | NULL | 473 | human |
| A9QXT2 | Cytochrome b; | CYTB; | NULL | 380 | human |
| D3DTW3 | Insulin-like growth factor 2 mRNA binding protein 1, isoform CRA_a; | IGF2BP1; | NULL | 441 | human |
| B2R550 | Apelin-28; cDNA, FLJ92342, Homo sapiens apelin (APLN), mRNA; | APLN; | NULL | 122 | human |
| A6Z7E2 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| E9PNR9 | Protein arginine N-methyltransferase 1; Fragment; | PRMT1; | NULL | 160 | human |
| F2Z3L6 | Beta-glucuronidase; | GUSB; | NULL | 144 | human |
| T1Q6I5 | NADH-ubiquinone oxidoreductase chain 6; EC 1.6.5.3; | ND6; | NULL | 174 | human |
| E9PRX5 | Putative protein ZNF720; | ZNF720; | NULL | 52 | human |
| W8D7D4 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| Q85KX2 | Cytochrome b; | cytb; CYTB Cytb; | NULL | 378 | human |
| B5BU78 | Protein tyrosine phosphatase type IVA protein 1; | PTP4A1; | NULL | 173 | human |
| C9J4Z3 | 60S ribosomal protein L37a; Ribosomal protein L37a, isoform CRA_c; | RPL37A; | NULL | 68 | human |
| Q85KU6 | Cytochrome b; | cytb; CYTB Cytb; | NULL | 378 | human |
| Q6RQJ1 | Cytochrome b; | CYTB; | NULL | 378 | human |
| C8YFD1 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| B4DP72 | 2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial; cDNA FLJ55122, highly similar to Ubiquinone biosynthesis methyltransferaseCOQ5, mitochondrial (EC 2.1.1.-); | COQ5; | NULL | 253 | human |
| F2WEV7 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| B2Y8W7 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 318 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |